SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056704
Filing Date
2021-11-12
Accepted
2021-11-12 16:07:50
Documents
79
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20210930.htm   iXBRL 10-Q 2440184
2 EX-31.1 acor-ex311_7.htm EX-31.1 16408
3 EX-31.2 acor-ex312_9.htm EX-31.2 16040
4 EX-32.1 acor-ex321_8.htm EX-32.1 6665
5 EX-32.2 acor-ex322_6.htm EX-32.2 6777
  Complete submission text file 0001564590-21-056704.txt   9949125

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acor-20210930.xsd EX-101.SCH 60750
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20210930_cal.xml EX-101.CAL 64870
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20210930_def.xml EX-101.DEF 203576
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210930_lab.xml EX-101.LAB 504462
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210930_pre.xml EX-101.PRE 382963
11 EXTRACTED XBRL INSTANCE DOCUMENT acor-10q_20210930_htm.xml XML 2057352
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 211403467
SIC: 2836 Biological Products, (No Diagnostic Substances)